Chagas disease

  title={Chagas disease},
  author={Jos{\'e} Antonio P{\'e}rez-Molina and Israel Molina},
  journal={The Lancet},
Chagas disease is an anthropozoonosis from the American continent that has spread from its original boundaries through migration. It is caused by the protozoan Trypanosoma cruzi, which was identified in the first decade of the 20th century. Once acute infection resolves, patients can develop chronic disease, which in up to 30-40% of cases is characterised by cardiomyopathy, arrhythmias, megaviscera, and, more rarely, polyneuropathy and stroke. Even after more than a century, many challenges… Expand
Chagas Disease: From Discovery to a Worldwide Health Problem
This review aims to describe the spread of CD cases worldwide since its discovery until it has become a global public health concern. Expand
Trypanocidal treatment of Chagas disease.
This review focuses on the aspects that allow clinicians to make the best use of currently available drugs for chagas disease, and discusses new therapeutic options and ongoing research in the field. Expand
Chapter 2 Chagas Disease in the Yucatan Peninsula , Mexico
American trypanosomiasis or Chagas disease is caused by the protozoan Trypanosoma cruzi, which affects a wide variety of hosts including the man, until now treatment options or vaccines developed areExpand
Drug discovery for chagas disease : A viewpoint Jadel
Chagas disease is a neglected tropical disease caused by the protozoan parasite Trypanosoma cruzi. It is a significant public health problem, affecting millions of people worldwide. And although itExpand
WHF IASC Roadmap on Chagas Disease
The WHF IASC Roadmap proposes strategies and evidence-based solutions for healthcare professionals, health authorities and governments to help overcome the barriers to comprehensive care for Chagas disease patients. Expand
Orbital Cellulitis in Chagas Disease: An Unusual Presentation.
A case of a 47-year-old healthy farmer diagnosed with a right orbital cellulitis refractory to systemic antibiotics, who had a proper recovery and continued with a regular follow-up to monitor the possible development of a chronic phase of Chagas disease. Expand
Current trends in the pharmacological management of Chagas disease
It was possible to conclude that the use of benznidazole in combination with other compounds showed better results when compared with its use as a single therapy. Expand
An Animal Model of Acute and Chronic Chagas Disease With the Reticulotropic Y Strain of Trypanosoma cruzi That Depicts the Multifunctionality and Dysfunctionality of T Cells
The T cell response is investigated in a murine model of acute and chronic ChD, supporting the previous results showing that similar to humans, the T. cruzi persistence in mice promotes the dysfunctionality of T cells, and these changes might correlate with ChD progression. Expand
American trypanosomiasis and Chagas disease: Sexual transmission.
Investigation of the routes of transmission of Trypanosoma cruzi parasites and the distribution of Chagas disease found that the blood protozoan T. cruzi can be transmitted sexually from infected males and females to naïve mates has implications for public health. Expand
ST-Elevation in a Patient with Acute Chagas Disease
Chagas disease has recently gained prominence, since new means of infection have become more common, including blood transmission and consumption of food contaminated with feces from a given vector. Expand